Telsey Advisory Group Expects Reduced Earnings for Zevia PBC

Zevia PBC (NYSE:ZVIA) – Analysts at Telsey Advisory Group cut their FY2024 earnings per share (EPS) estimates for Zevia PBC in a note issued to investors on Tuesday, January 14th. Telsey Advisory Group analyst D. Telsey now expects that the company will post earnings per share of ($0.30) for the year, down from their prior forecast of ($0.27). Telsey Advisory Group currently has a “Market Perform” rating and a $4.00 target price on the stock. The consensus estimate for Zevia PBC’s current full-year earnings is ($0.30) per share. Telsey Advisory Group also issued estimates for Zevia PBC’s Q4 2024 earnings at ($0.07) EPS, Q1 2025 earnings at ($0.05) EPS, Q4 2025 earnings at ($0.03) EPS, FY2025 earnings at ($0.16) EPS and FY2026 earnings at ($0.09) EPS.

Separately, The Goldman Sachs Group upped their price target on shares of Zevia PBC from $1.15 to $3.75 and gave the company a “neutral” rating in a report on Tuesday.

Zevia PBC Stock Up 9.0 %

ZVIA stock opened at $4.81 on Thursday. Zevia PBC has a twelve month low of $0.62 and a twelve month high of $4.94. The stock has a market capitalization of $350.81 million, a price-to-earnings ratio of -12.64 and a beta of 0.66. The firm’s fifty day simple moving average is $3.08 and its two-hundred day simple moving average is $1.72.

Zevia PBC (NYSE:ZVIA) last released its quarterly earnings results on Wednesday, November 6th. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.11) by $0.07. Zevia PBC had a negative return on equity of 38.02% and a negative net margin of 14.02%. The company had revenue of $36.37 million during the quarter, compared to analyst estimates of $38.53 million. During the same quarter last year, the business posted ($0.16) earnings per share.

Insider Buying and Selling at Zevia PBC

In related news, Director Rosemary L. Ripley sold 2,567,006 shares of Zevia PBC stock in a transaction dated Thursday, December 5th. The shares were sold at an average price of $1.90, for a total transaction of $4,877,311.40. Following the completion of the sale, the director now owns 2,719,258 shares in the company, valued at $5,166,590.20. This trade represents a 48.56 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 12.55% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Zevia PBC

A number of institutional investors have recently modified their holdings of the stock. Point72 Asia Singapore Pte. Ltd. bought a new position in Zevia PBC in the second quarter worth approximately $26,000. Renaissance Technologies LLC lifted its holdings in shares of Zevia PBC by 128.7% in the 2nd quarter. Renaissance Technologies LLC now owns 69,300 shares of the company’s stock worth $47,000 after buying an additional 39,000 shares during the period. ORG Wealth Partners LLC bought a new position in shares of Zevia PBC during the 4th quarter worth $129,000. XTX Topco Ltd purchased a new position in shares of Zevia PBC during the third quarter valued at $50,000. Finally, Nwam LLC bought a new stake in shares of Zevia PBC in the third quarter valued at about $39,000. 53.21% of the stock is owned by hedge funds and other institutional investors.

About Zevia PBC

Zevia PBC, a beverage company, develops, markets, sells, and distributes various carbonated beverages in the United States and Canada. It offers soda, energy drinks, organic tea, and kidz drinks. The company offers its products through a network of food, drug, warehouse club, mass, natural, convenience, and e-commerce channels, as well as grocery distributors and natural product stores and specialty outlets.